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INTRODUCTION 
 
Cirrhosis is a chronic disease of the liver that leads to a number of 
complications, some of which may eventually prove fatal. There are reports of 
association of chronic liver disease with autonomic neuropathy.1 
 
Patients with chronic liver disease who have associated autonomic 
neuropathy respond inappropriately or defectively to major events such as 
septicaemia and variceal haemorrhage.2 Autonomic Neuropathy (AN) is 
associated with hemodynamic impairment and with increased vasoactive drug 
requirements during liver transplantation, probably associated with impaired 
reflex vasoconstrictor responses to surgical manipulations and changes of 
blood volume. AN may be associated with a greater surgical risk during liver 
transplantation. Preoperative evaluation of AN may select a high-risk 
population of liver transplant recipients.3 
 
The present study was undertaken primarily to investigate autonomic 
functions in hepatic cirrhosis (in both alcoholics and non-alcoholics), analyse 
characteristics of patients who develop autonomic neuropathy, and to 
determine the relationship between severity of liver damage and extent of 
autonomic function impairment. 
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Electrocardiogram is a very simple and noninvasive investigation in 
diagnosing asymptomatic autonomic dysfunction. It helps in early recognition 
of cardiac dysautonomia, which is asymptomatic autonomic dysfunction and 
precursor of symptomatic autonomic dysfunction. This also helps in taking 
sufficient precaution to delay or arrest its progression by various measures. 
 
In this study the prevalence of various ECG abnormalities and cardiac 
dysautonomia in cirrhotic patients are assessed by various ECG markers. 
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AIMS OF THE STUDY 
 
1) To study the prevalence of various ECG abnormalities in cirrhotic 
patients as compared to controls. 
2) To study the prevalence of  cardiac dysautonomia in cirrhotic        
       patients by various ECG markers. 
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REVIEW OF LITERATURE 
 
HEPATIC CIRRHOSIS 
Cirrhosis is a pathologically defined entity that is associated with a 
spectrum of characteristic clinical manifestations. The cardinal pathologic 
features reflect irreversible chronic injury of the hepatic parenchyma and 
include extensive fibrosis in association with the formation of regenerative 
nodules.4  
 
These features result from hepatocyte necrosis, collapse of the 
supporting reticulin network with subsequent connective tissue deposition, 
distortion of the vascular bed and nodular regeneration of the remaining liver 
parenchyma. 
 
The central event leading to hepatic fibrosis is activation of the hepatic 
stellate cells. Upon activation by factors released by hepatocytes and kupffer 
cells, the stellate cell assumes a myofibroblast like conformation and under the 
influence of cytokines such as transforming growth factor β (TGF-β),produces 
fibril forming type-І collagen. The precise point at which the fibrosis becomes 
irreversible is unclear. 
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CAUSES OF CIRRHOSIS5 
• Alcohol related(most common) 
• Chronic vial hepatitis, types B, C, and D 
• Primary biliary cirrhosis  
• Primary sclerosing cholangitis 
• Metabolic diseases 
• Autoimmune hepatitis  
• Hepatic venous outflow obstruction(Budd Chiari Syndrome, 
Constrictive Pericarditis) 
• Indian childhood cirrhosis 
• Toxins and therapeutic agents(Methotrexate, Amiodarone) 
• Cryptogenic cirrhosis 
CLINICAL FEATURES 
Clinical features of cirrhosis derive from the morphologic alterations 
and often reflect the severity of liver damage than the etiology of the 
underlying liver disease. Loss of functioning hepatocellular mass may lead to 
jaundice ,edema, coagulopathy and a variety of metabolic abnormalities ; 
fibrosis and distorted vasculture lead to portal hypertension and its sequelae, 
including gastroesophageal varices and splenomegaly. Ascites and hepatic 
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encephalopathy result from both hepatocellular insufficiency and portal 
hypertension.4 
 
COMPLICATIONS: 
 The most important complications of cirrhosis are 
 Portal hypertension 
 Ascites 
 Variceal bleeding 
 Splenomegaly 
 Hepatic encephalopathy 
 Hepatorenal Syndrome 
 Hepatopulmonary Syndrome 
 Hepatocellular carcinoma 
 Spontaneous bacterial peritonitis 
 Autonomic dysfunction 
 Insulin resistance 
 
DIAGNOSIS: 
Various investigatory modalities available for the diagnosis of cirrhosis 
are  
 Liver biopsy  
 Ultrasound 
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 CT scan abdomen 
 Laparoscopy 
 Radioisotope scanning 
 
Since neither liver biopsy nor scanning have a diagnostic sensitivity 
greater than 90% (USG 87%, biopsy 62%), it has been proposed that 
ultrasound be done before liver biopsy is performed6. If cirrhosis is suspected 
on ultrasound (or clinical findings) at least two separate liver biopsy specimens 
should be taken for histology. If histology does not show cirrhosis but the 
specimen shows fragmentation, fibrosis or architectural disruption, this 
together with the ultrasound result should allow a diagnosis of cirrhosis to be 
made. 
 
 
CHILD-PUGH SCORING. 
 
This is a scoring system developed for staging cirrhotic liver disease. It 
is used for assessing prognosis and operative mortality of cirrhosis patients. 
This scoring system is based on both clinical and laboratory parameters namely 
the levels of bilirubin, albumin, prothrombin time prolongation, the presence of 
ascites and encephalopathy. Patients are classified as Child class A, B, or C 
according to the total score of 5–6, 7–9, and 10–15 respectively. The prognosis 
worsens with increasing score. 
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CHILD-PUGH SCORING 
 
Score 
 
 
 
Parameter 
 
 
1 
 
2 
 
3 
 
 
Ascites 
 
Encephalopathy 
 
Albumin(g/l) 
 
Bilirubin(µmol/l 
 
Prothrombin 
time(sec 
>control) 
 
Absent 
 
None 
 
>35 
 
<34 
 
<4 
 
Slight to 
moderate 
Grade 1–2 
 
28–35 
 
34–52 
 
4–6 
 
Tense 
 
Grade 3–4 
 
<28 
 
>52 
 
>6 
 
 
 
 
 
CIRRHOSIS AND THE CARDIOVASCULAR SYSTEM: 
 
The cardiovascular effects of cirrhosis are wide-ranging and encompass 
not only effects on the systemic and splanchnic circulation but also on the heart 
itself. 
Cirrhosis involves the cardiovascular system in the following ways. 
1. Cirrhotic cardiomyopathy 
2. Autonomic dysfunction 
3. Hyperdynamic circulation 
4. QT prolongation 
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Cirrhosis is associated with an increased cardiac output and heart rate as 
well as decreased systemic peripheral vascular resistance and blood 
pressure5.Splanchnic arterial vasodilatation and impaired autonomic activity 
play a role.7 
 
CIRRHOTIC CARDIOMYOPATHY 
Cirrhotic cardiomyopathy is recognized with abnormal cardiac 
contractility particularly with pharmacological and physiological stress8.A 
reduction in myocardial β adrenergic receptor signal transduction plays a role, 
perhaps due to changes in the lipid content of the cardiac plasma membrane or 
an inhibitory effect of jaundice on adenyl cyclase. Experimental studies have 
shown decreased β adrenergic receptor density and receptor desensitisation in 
cardiocytes of cirrhotic rats9. In addition, leucocytes of cirrhotic patients also 
present decreased abundance of β adrenoreceptor10 . 
 
Heart receptor and post receptor defects are supported by the 
demonstration of reduced function and expression of cardiac G proteins in 
cirrhotic animals and impaired cardiac excitation-contraction coupling in portal 
hypertensive rats11 .Plasma membrane fluidity and ion channel function are 
impaired in cirrhosis.12 
 
  10 
Left ventricular wall thickness may be increased. The cause of increased 
cardiac wall thickness is not fully understood. But the role of renin angiotensin 
aldosterone system (RAAS) and adrenergic hyperactivity has been considered.  
While systolic function is well preserved at rest there is chronotropic and 
inotropic incompetence on exercise13. 
 
Left ventricular ejection fraction is decreased on exercise. The failure of 
the ejection fraction to increase despite an increase in venous return is 
suggestive of diastolic dysfunction13. 
   
Cardiac dysfunction may be subclinical, presenting only after liver 
transplantation5. This may presumably due to the reduction in after-load that 
accompanies the generalized vasodilatation of advanced liver disease13. 
 
Studies using brain natriuretic peptide (BNP) as a marker of high 
ventricular pressure reflecting Cardiac dysfunction have shown that the levels 
of BNP correlated closely with the severity of Cirrhosis as measured by Child-
Pugh class and also the degree of Portal hypertension as measured by hepatic 
venous pressure gradient13.Changes were seen equally in patients with 
alcoholic and nonalcoholic liver diseases.  
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PATHOGENESIS OF AUTONOMIC DYSFUNCTION AND 
HYPERDYNAMIC CIRCULATION: 
 
Hyperdynamic circulation is a common and long-recognized feature of 
patients with advanced cirrhosis14, consisting of elevated cardiac rate and 
output and reduced peripheral vascular resistance, so that arterial pressure is 
tendentially or frankly reduced14.  Owing to the importance of autonomic 
function in cardiovascular homeostasis, it may be involved in the pathogenesis 
of the hyperdynamic circulation. 
 
The setting of the hyperdynamic circulatory syndrome is the 
pathogenetic background of complications such as renal sodium and water 
retention and hepatorenal syndrome15.  
 
CAUSES FOR HYPERDYNAMIC CIRCULATION16,17 
  
1. Splanchnic blood pooling 
2. Opening of portal-systemic collaterals 
3. Arterial vasodilation, mainly splanchnic 
4. Compensatory increase in blood volume 
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The pathogenesis of arterial vasodilation is still debated. It has been well 
recognized that blood nor-adrenaline levels are elevated in cirrhotic patients18,19  
 
Baseline nor-adrenaline levels correlate positively with the severity of 
the cirrhosis20. There has been no satisfactory explanation for this 
observation18. The high Nor- Epinephrine (NE) levels can be reduced by head-
out water immersion testing, suggesting that a decreased effective plasma 
volume may be the stimulus for the increased secretion of endogenous NE21. 
 
It is known that nor-epinephrine levels are affected by a variety of 
factors, including metabolism in the liver and neuronal uptake and 
intraneuronal metabolism. There is no current evidence to suggest that a defect 
in the metabolism of nor-epinephrine in the liver contributes significantly to 
excessive plasma nor-epinephrine22..Neuronal up-take and intraneuronal 
metabolism of nor-epinephrine, however, have not been studied in cirrhotics. It 
is possible that the excessive nor-epinephrine is a compensatory response to 
vasodilatation and other hemodynamic changes seen in liver disease. In 
addition, there may be alterations of end-organ responsiveness, leading to a 
reduction in the pressor effects of NE. 
 
It has been suggested that the decreased vascular sensitivity of patients 
with ESLD to vasoconstrictors in the presence of increased levels of 
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vasodilators (glucagon, atrial natriuretic factor, platelet-activating factor, bile 
salts) is responsible for this hyper dynamic circulatory state. Metabolites of 
nitric oxide (nitrites and nitrates) are also increased in ESLD. Moderately 
increased levels of endothelin-1 in patients with ESLD can also contribute to 
vasodilatation by stimulating synthesis of nitric oxide in the endothelium. 
 
It has been hypothesised that a porto-systemic shunt may diminish the 
hepatic clearance of gut derived vasoactive agents. 
 
 Blood volume expansion follows renal retention of sodium and water, 
which, in turn, is evoked by secondary hyperaldosteronism, activation of 
sympathetic nervous system, enhanced secretion of arginine vasopressin,and 
reduced renal perfusion23,24. 
 
AUTONOMIC DYSFUNCTION (AD) 
 
Autonomic Dysfunction can contribute to the hyper dynamic circulatory 
syndrome in several ways. A sympatho-vagal imbalance with a prevalent 
parasympathetic dysfunction would lead to a defective inhibitory vagal tone on 
the cardiac pacemaker. An acceleration of heart rate would ensue and 
contribute to increased cardiac output along with an enhanced cardiac 
preload25. Moreover, in the subset of patients with defective sympathetic 
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function, this may contribute to the blunted cardiovascular response to 
adrenergic vasoconstrictors and maneuvers enhancing the 
sympathoadrenergic drive, which have been described in cirrhosis26,27 
 
AD is commonly detected in patients with cirrhosis, and its prevalence 
increases in parallel with the severity of liver disease, as does the hyper 
dynamic circulatory syndrome. Moreover, the presence of both abnormalities 
heralds an adverse prognosis28,26. 
 
Desperate events may contribute to the development of AD, including 
factors affecting nerve integrity, such as alterations in lipid metabolism, 
vitamin E deficiency, alcohol intake, immunologic mechanisms, and retention 
of toxic metabolites29.Moreover, vagal function may be inhibited by elevated 
angiotensin II production30 
 
This abnormality of the nervous system appears to be unrelated to the 
toxic effects of chronic alcohol use, because cross-sectional studies have shown 
an equal prevalence of AN in alcohol and non–alcohol related liver disease. 
The autonomic neuropathy is probably related to the changes resulting from 
liver disease, although the precise mechanism remains unclear. 
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Cold pressor tests suggest that cirrhotic patients have relative 
hyporesponsiveness to ά-adrenoreceptor stimulation. The failure of these 
compensatory mechanisms in the presence of overwhelming stress may explain 
the apparent increase in mortality in patients with chronic liver disease and 
autonomic neuropathy. 
 
QTc PROLONGATION 
 
AD is associated with an impairment of free water generation and 
hyponatremia 31,32, and is likely involved in the pathogenesis of prolonged 
electrocardiographic Q-T interval 33, a common finding in advanced cirrhosis 
with an adverse prognostic significance 34. The QT interval on ECG is 
frequently prolonged. Correction of the prolonged QT interval has been 
documented in post transplant patients. 
 
Recently, Ward and colleagues 35  described a decrease in K+ current in 
ventricular myocytes of cirrhotic rats, which would result in a tendency to 
prolong QT intervals. This is in agreement with the results of Bernardi and 
colleagues showing a prolonged QT interval and other electrophysiological 
abnormalities in cardiac excitation and repolarisation in cirrhotic patients. It 
has been suggested that androgen deficiency may also cause Q-Tc prolongation 
in male patients with cirrhosis.36 
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CLINICAL FEATURES OF AUTONOMIC NEUROPATHY37 
 
 SYSTEM     SYMPTOMS 
 
1. Cardiovascular              1. Postural hypotension 
      2. Painless MI 
      3. Resting tachycardia 
      4. Loss of heart rate variation 
 
2. Gastrointestinal   1. Esophageal dysmotility    
   2. Gastric atony 
   3. Diarrhoea 
   4. Colonic atony 
 
 
3. Respiratory   1. Respiratory arrest 
 
4. Urogenital   1. Bladder dysfunction 
   2. Impotence 
   3. Retrograde ejaculation 
   4. Loss of testicular sensation 
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5. Pupillary abnormalities                       1. Reduced resting diameter 
2. Delayed (or) absent response to 
light.   
3. Diminished hippus 
 
6. Vasomotor                1. Loss of skin Vasomotor                                           
                                                                    Responses 
   2. Peripheral vascular changes 
   3. Dependent edema 
 
7. Sudomotor   1. Anhydrosis 
   2. Gustatory sweating 
    
 
 
AUTONOMIC NERVOUS SYSTEM 
The nervous system is divided into the somatic nervous system which 
controls organs under voluntary control (mainly muscles) and the Autonomic 
Nervous System (ANS) which regulates individual organ function and 
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homeostasis, and for the most part is not subject to voluntary control. It is also 
known as the visceral or automatic system.  
 
The ANS is predominantly an efferent system transmitting impulses 
from the Central Nervous System (CNS) to peripheral organ systems. Its 
effects include control of heart rate and force of contraction, constriction and 
dilatation of blood vessels, contraction and relaxation of smooth muscle in 
various organs, visual accommodation, pupillary size and secretions from 
exocrine and endocrine glands.  
 
Autonomic nerves constitute all of the efferent fibres which leave the 
CNS, except for those which innervate skeletal muscle. There are some afferent 
autonomic fibres (i.e. transmit information from the periphery to the CNS) 
which are concerned with the mediation of visceral sensation and the regulation 
of vasomotor and respiratory reflexes, for example the baroreceptors and 
chemoreceptors in the carotid sinus and aortic arch which are important in the 
control of heart rate, blood pressure and respiratory activity. These afferent 
fibres are usually carried to the CNS by major autonomic nerves such as the 
vagus, splanchnic or pelvic nerves, although afferent pain fibres from blood 
vessels may be carried by somatic nerves.  
  19 
The ANS is primarily involved in reflex arcs, involving an autonomic or 
somatic afferent limb, and then autonomic and somatic efferent limbs. For 
instance, afferent fibres may convey stimuli from pain receptors, or 
mechanoreceptors and chemoreceptors in the heart, lungs, gastrointestinal tract 
etc. 
There may then be a reflex response to this involving autonomic efferent 
fibres causing contraction of smooth muscle in certain organs (e.g. blood 
vessels, eyes, lungs, bladder, gastrointestinal tract) and influencing the function 
of the heart and glands. The efferent limbs of these reflexes may also involve 
the somatic nervous system (e.g. coughing and vomiting). Simple reflexes are 
completed entirely within the organ concerned, whereas more complex reflexes 
are controlled by the higher autonomic centres in the CNS, principally the 
hypothalamus.  
 
The ANS is divided into two separate divisions called the 
Parasympathetic and Sympathetic Systems, on the basis of anatomical and 
functional differences. Both of these systems consist of myelinated 
preganglionic fibres which make synaptic connections with unmyelinated 
postganglionic fibres, and it is these which then innervate the effector organ. 
These synapses usually occur in clusters called ganglia. Most organs are 
innervated by fibres from both divisions of the ANS, and the influence is 
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usually opposing (e.g. the vagus slows the heart, whilst the sympathetic nerves 
increase its rate and contractility), although it may be parallel (e.g. the salivary 
glands). Parasympathetic fibres from the vagus (through acetyl choline) and 
sympathetic fibres (through nor-adrenaline) from upper 4 to 5 thoracic ganglion 
innervate heart and mediate autonomic control. 
 
CARDIAC DYSAUTONOMIA 38     
Cardiac dysautonomia refers to autonomic dysfunction of heart. It 
appears to be the most frequent autonomic dysfunction in patients with 
cirrhosis. There are two terms. 
1. Autonomic Neuropathy 
               Refers to combined and objective evidence of autonomic 
involvement. 
2. Autonomic Dysfunction 
         Refers to abnormal cardiovascular tests in absence of clinical 
symptoms. 
Autonomic Dysfunction in cirrhosis with portal hypertension is 
common but symptomatic autonomic neuropathy is less common. 
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EFECTS OF SYMPATHOVAGAL IMBALANCE 39  
 
1. Impairs angina recognition. 
2. Alters threshold for ischemia 
 -increased heart rate and blunted chronotropic response to exercise. 
 -impaired coronary casomotor regulation. 
3. Abnormailty in diastolic and systolic function. 
 -contributes to cardiomyopathy. 
4. Increased risk of ventricular arrhythmia 
 - contributes to sudden cardiac death. 
5. Altered circadian pattern of triggering acute cardiac events 
 -leads to loss of nocturnal protection against acute MI. 
6. Altered circadian blood pressure regulation leads to 
            - increased cardiac mass 
 -causes haemodynamic instability in perioperative period. 
 
CLINICAL PRESENTATION 
 
Autonomic damage may be asymptomatic and thus be detected 
incidentally, even if symptomatic, the condition goes unnoticed for a 
considerable period of time partly because of the vagueness of many of early 
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symptoms. The proportion of asymptomatic subjects increases with increasing 
duration of the disease. 
 
The features of cardiac autonomic neuropathy include  
 
1. Exercise intolerance 
2. Postural hypotension 
3. Resting tachycardia 
4. Fixed heart rate. 
5. Silent myocardial infarction. 
 
Chronic liver disease has been shown to be associated with autonomic 
neuropathy (AN) as well as hemodynamic and circulatory disturbances. 1                                                                        
 
This abnormality of the nervous system appears to be unrelated to the 
toxic effects of chronic alcohol use, because cross-sectional studies have shown 
an equal prevalence of AN in alcohol- and non–alcohol-related liver disease. 
 
 In a longitudinal study in patients with Child A liver disease, the 4-year 
mortality was found to be 30% in patients with autonomic neuropathy 
compared with 6% in patients without autonomic dysfunction multiple logistic 
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regression analysis showed that the presence of autonomic neuropathy and 
severity of liver disease were independent risk factors of mortality40. 
 
EXERCISE INTOLERANCE 
 
Patients with Autonomic Neuropathy achieve a lower heart rate, blood 
pressure and cardiac output on exercise compared to normal people. 
 
POSTURAL HYPOTENSION 
 
Dizziness, fainting blackouts or visual impairment on standing are the 
clinical presentations of Postural hypotension and it is the most prominent and 
disabling cardiovascular manifestation of Autonomic Neuropathy. The blood 
pressure fall may be worsened by a variety of drugs like diuretics and 
hypotensive agents including β blockers and nitrates. 
 
The main lesion in Postural hypotension is probably in the efferent limb 
of the reflex with damaged sympathetic vasoconstrictor fibres in the splanchnic 
bed, muscle and skin. The hypotension may be augmented by a diminished 
plasma rennin response on standing, which is due to impaired sympathetic 
innervation to juxtaglomerular apparatus, one of the sequelae of autonomic 
dysfunction. 
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RESTING TACHYCARDIA  
 The mean resting heart rate of patients with cirrhosis of the liver has 
been found to be increased when compared to the controls due to the presence 
of autonomic neuropathy in these patients. 
Vagal tone, as assessed by baroreflex sensitivity is markedly depressed 
in cirrhotic patients awaiting liver transplantation41. This is the reason for 
resting tachycardia in many cirrhotics. 
 
FIXED HEART RATE 
Chronic liver disease is accompanied by a significant Heart Rate 
Variability decrease. Heart rate shows less diurnal variation with increasing 
autonomic damage. Loss of the normal cardiac slowing at night results from 
vagal damage. With severe damage there is a loss of minute to minute and 
second to second variation in heart rate, resulting in relatively fixed heart rate. 
 
SILENT MYOCARDIAL INFARCTION 
 
Autonomic Neuropathy may reduce the perception of cardiac ischaemic 
pain. The incidence of coronary artery disease is low in cirrhotics. It is only 
about a quarter of that among total cases examined without cirrhosis. Cirrhotics 
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are less liable to coronary and aortic atheroma than the rest of the population5. 
This may also be due to the low peripheral vascular resistance in these patients. 
 
ECG CHANGES IN CIRRHOTICS 
The QT interval is an approximate measure of ventricular electrical 
recovery after excitation. A prolonged QT interval identifies patients at 
increased risk for sudden cardiac death in a variety of clinical situations, in 
patients with alcohol-related liver disease (ALD) who continue to drink to 
excess, QT prolongation is associated with sudden death due to arrhythmias42 . 
The cause of QT prolongation in liver disease is not clear. 
 
A relationship between the severity of autonomic damage and extent of 
the QT corrected for heart rate (QTc) prolongation in ALD and non-ALD has 
been reported, and it was suggested that autonomic neuropathy was the cause 
of the prolonged QT interval. Liver transplantation reverses prolonged QT 
interval. The etiology of liver disease did not affect the prevalence of abnormal 
QTcmax interval. Prolonged QT interval correlated positively with increasing 
severity of liver disease, as indicated by the Child-Pugh score.   
 
Another important ECG change noted commonly in cirrhotics is the 
decreased variation of electrocardiographic R-R interval. 
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ASSESSMENT OF CARDIOVASCULAR AUTONOMIC 
DYSFUNCTION 
Objective measurement of autonomic nerve damage is based on 
cardiovascular reflexes as these are reliable and quantitative noninvasive 
methods to access autonomic nervous system function. Implicit in the use of 
cardiovascular reflex test is the assumption that it reflects damage throughout 
the autonomic nervous system. This is largely true except for the very early 
manifestation such as sweating loss on the feet and impotence which may 
antedate abnormal cardiovascular tests. 
 
 
TESTS FOR PARASYMPATHETIC FUNCTION 
1. Heart rate response to deep breathing  
2. Heart rate response to standing 
3. Heart rate response to valsalva maneuver 
 
 
TESTS FOR SYMPATHETIC FUNCTION 
1. BP response to standing 
2. BP response to sustained hand grip. 
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CARDIAC AUTONOMIC FUNCTION TESTS 
 
CARDIAC AUTONOMIC FUNCTION 
TESTS 
 
NORMAL 
 
ABNORMAL 
 
heart rate response to deep breathing(E:I ratio) 
 
≥ 1.1 
 
< 1.1 
 
heart rate response to standing  (30:15 ratio) 
 
> 1.04 
 
< 1.0 
 
Valsalva ratio 
 
> 1.21 
 
< 1.20 
 
BP response to standing (fall in systolic BP) 
 
<10mmHg 
 
> 20 mm Hg 
 
BP response to sustained hand grip (increase in 
diastolic BP) 
 
>16mmHg 
 
<10mmHg 
 
 
HEART RATE VARIATION ON DEEP BREATHING 
 
The normal acceleration and deceleration of heart rate during respiration 
(sinus arrhythmia) is reduced early in course due to cardiac vagal involvement. 
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This phenomenon provides the basis for the simplest and most sensitive test for 
the presence of cardiac dysautonomia. 
 
The patient takes breath deeply and evenly at a rate of six breaths per 
minute, i.e. five seconds for inspiration and five seconds for expiration. The 
ratio of the mean of the longest RR interval during expiration to the mean of 
the shortest RR interval during inspiration is calculated from the ECG 
recording. This is called the E: I ratio and it indicates autonomic dysfunction if 
< 1.1. 
 
HEART RATE RESPONSE TO VALSALVA MANOEUVRE 
The subject was seated quietly and then asked to blow into a mouthpiece 
attached to a manometer, holding it at a pressure of 40 mm Hg for 15 seconds 
while a continuous electrocardiogram (ECG) was recorded. The manoeuvre 
was repeated three times with one minute interval in between and results were 
expressed as: 
 
           longest R-R interval after the manoeuvre                                           
Valsalva ratio = --------------------------------------------------------------   
           Shortest R-R Interval during the manoeuvre                                                 
 
The mean of the three Valsalva ratios was taken as the final value. 
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IMMEDIATE HEART RATE RESPONSE TO STANDING 
 
The test was performed with the subject lying quietly on a couch while 
the heart rate was recorded continuously on an electrocardiograph. The patient 
was then asked to stand unaided and the point at starting to stand was marked 
on ECG paper. The shortest R-R interval at or around the 15th beat and the 
longest R-R interval at around the 30th beat after starting to stand were 
measured with a ruler. The characteristic heart rate response was expressed by 
30:15 ratios. 
 
BLOOD PRESSURE RESPONSE TO STANDING 
This test measured the subject’s blood pressure with a 
sphygmomanometer while he was lying quietly and one minute after he was 
made to stand up. The postural fall in blood pressure was taken as the 
difference between the systolic pressure lying and the systolic blood pressure 
standing. The test was repeated three times and the mean was calculated. 
 
BLOOD PRESSURE RESPONSE TO SUSTAINED HAND GRIP 
The blood pressure of the patient was taken three times before the 
manoeuvre. A sphygmomanometer was used for sustained handgrip 
manoeuvre. The patient was asked to grip the inflatable rubber bag and apply 
maximum voluntary pressure possible. The reading during maximum voluntary 
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contraction is noted. Thereafter, the patient was asked to maintain 30% of 
maximum voluntary contraction for as long as possible up to five minutes. 
Blood pressure was measured at one minute intervals during the handgrip. The 
result was expressed as the difference between the highest diastolic blood 
pressure during the handgrip exercise and the mean of the three diastolic blood 
pressure readings before the handgrip began. 
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MATERIALS AND METHODS 
 
STUDY POPULATION 
 Study group- 50 patients with cirrhosis with portal hypertension 
Control group- 50 age and sex matched controls. 
 
PLACE OF STUDY 
       
       Department of Medicine 
       Department of Gastroenterology 
       Stanley Medical College 
       Chennai-1 
 
PERIOD OF STUDY 
       June 2005 to December 2005 
 
METHODS   
 
All the study group patients and controls were subjected for thorough 
physical examination. Blood samples were drawn and subjected to estimation 
of estimation of liver function, renal   function and glucose levels. 
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EXCLUSION CRITERIA 
 
1. Age above 60 years. 
2. Documented ischemic heart disease 
3. Documented valvular/congenital heart disease 
4. Hypertension and Diabetes mellitus. 
5. Chronic obstructive pulmonary disease 
6. Drugs-β blockers, digoxin, calcium channel blockers 
7. Features of hypothyroidism 
8. Uraemia 
9. Features of parkinsonism and rheumatoid arthritis 
 
Cardiovascular autonomic dysfunction was assessed by the following 
maneuvers. 
 
PARASYMPATHETIC FUNCTION 
1. Tachycardia in resting ECG 
2. heart rate response to deep breathing(E:I ratio) 
 
SYMPATHETIC FUNCTION 
1. BP response to standing 
2. QTc prolongation 
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ELECTROCARDIOGRAM 
 
Resting ECG was taken in both the study and control group using a 
three leaded Schiller Cardiovit AT machine. ECG during deep breathing was 
recorded only in the study group using single leaded BPL ECG machine. The 
lead considered here is lead II. 
 
The subjects were made to lie down quietly. Then they were asked to 
take deep breath in and out at a rate of six breaths per minute (i.e) five seconds 
for inspiration and five seconds for expiration which produces a maximum 
heart rate variation. A continuous ECG was recorded for one minute. 
 
E: I ratio was measured which is the ratio of the mean of the longest RR 
interval during expiration to the mean of the shortest RR interval during 
inspiration. it indicates autonomic dysfunction if < 1.1. 
 
QTc INTERVAL 
R-R and QT intervals are measured with a meter on the resting ECG 
tracing. The lead considered here is lead V2.The QT interval was measured 
from the beginning of the QRS complex to the end of the downslope of the T 
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wave (crossing the isoelectric line). When a ‘U’ wave was present, the QT 
interval was measured to the nadir of T and U waves. 
The corrected QT interval for the previous cardiac cycle length (QTc) 
was calculated using Bazett’s formula43                                
                                                                QT 
         QTc = ------------ 
                                                          √R-R(sec) 
A QTc >460 msec is considered abnormally prolonged. 
 
BLOOD PRESSURE RESPONSE TO STANDING 
This test measured the subject’s blood pressure with a 
sphygmomanometer while he was lying quietly and one minute after he was 
made to stand up. The postural fall in blood pressure was taken as the 
difference between the systolic pressure lying and the systolic blood pressure 
standing. The test was repeated three times and the mean was calculated. The 
test is taken as positive when the fall in systolic blood pressure was more than 
20 mm Hg. 
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OBSERVATIONS 
AGE DISTRIBUTION 
 
CONTROL GROUP 
 
STUDY GROUP 
 
AGE IN 
YEARS NO. % NO % 
10-20 6 12 6 12 
21-30 3 6 2 4 
31-40 12 24 15 30 
41-50 22 44 20 40 
51-60 7 14 7 14 
More than half of the study populations were above 40 years of age. 
Most number of patients (40%) belonged to the age group of 41-50 years. 
STUDY GROUP (CIRRHOTICS) & DISEASE DURATION 
 
DURATION 
 
NO. OF PATIENTS 
 
PERCENTAGE 
0-1 yr 28 56 
1-2 yrs 9 18 
2-3 YRS 4 8 
3-4 yrs 6 12 
>4 yrs 3 6 
56% of the Cirrhotics have duration of the disease less than a year. 
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STUDY GROUP (CIRRHOTICS) & CHILD’S GRADING 
 
CHILD-PUGH CLASS 
 
NO.OF PATIENTS 
 
PERCENTAGE 
A 4 8 
B 42 84 
C 4 8 
TOTAL 50 100 
 
Maximum number of patients belonged to class B (84%) 
 
ECG ABNORMALITIES 
 
RESTING HEART RATE 
RESTING HEART RATE GROUPS 
Range (bpm) Mean (bpm) 
Study (Cirrhotics) 63-133 90 ± 16.98 
Control 56-108 76.78 ±  11.23 
 
*p = 0.0006    *Unpaired‘t’ test  
The mean resting heart rate of the Study group (Cirrhotics) (90 ± 16.98 bpm ) 
is significantly higher (p<0.05) than that of Control group (76.78 ±  11.23 
bpm). 
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R-R INTERVAL 
 
R-R INTERVAL 
 
GROUPS 
Range (msec) Mean (msec) 
Study (Cirrhotics) 451 – 952 690.54 ± 133.38 
Control 562 – 1071 797.98 ± 119.17 
  
*t = 4.24  p = 0.001  *Unpaired‘t’ test 
 R-R Interval of Study group (690.54 ± 133.38 msec) is significantly 
lower than Control group (797.98 ± 119.17 msec) (p<0.005) correlating with 
increased resting heart rate signifying parasympathetic damage. 
 
P-R INTERVAL 
 
P-R INTERVAL 
 
GROUPS 
Range (msec) Mean (msec) 
Study (Cirrhotics) 96 – 176 139.36 ± 19.09 
Control 118 – 200 143.76 ± 18.62 
 
*t = 1.17  p=0.24  *Unpaired‘t’ test 
 Both Study and Control Group show no statistically significant 
difference in P-R Interval (p<0.05). 
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QRS DURATION 
QRS DURATION  
GROUPS Range (msec) Mean (msec) 
Study (Cirrhotic) 60 – 120 58 ± 15.28 
Control 40– 80 58.4 ± 12.18 
 
*p=0.2675 
*Mann-Whitney Test 
 Both Study and Control Group show no statistically significant 
difference in QRS Duration (p>0.05). 
 
QRS AXIS 
QRS AXIS  
GROUPS Range (degrees) Mean (degrees) 
Study (Cirrhotics) -36      -     +120 42.12 ± 31.64 
Control 0         -      +100 48.92  ± 23.38 
 
*t = 1.22  p=0.22   
*Unpaired‘t’ test 
 Both Study and Control Group show no statistically significant 
difference in QRS Axis (p>0.05). 
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QTc INTERVAL 
QTc INTERVAL  
GROUPS Range (msec) Mean (msec) 
Study (Cirrhotic) 350 – 501 430.14 ±  41.43 
Control 312 – 498 376.36 ±  36.54 
 
*t = 6.88 p = 0.001   
*Unpaired‘t’ test 
 QTc Interval of Study group (430.14 +/- 41.43 msec) is significantly 
prolonged than Control group (376.36 +/- 36.54 msec) (p<0.005). 
 
E: I RATIO 
   STUDY GROUP (CIRRHOTICS) 
E:I RATIO NO. OF PATIENTS PERCENTAGE 
Normal ( ≥  1.1) 27 54 
Abnormal ( < 1.1 ) 23 46 
 
 46% of Study Group has abnormal E: I Ratio, which is suggestive of an 
early parasympathetic dysfunction. 
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SIGNIFICANT POSTURAL DROP OF SYSTOLIC BP (>20 mmHg) 
 
POSTURAL DROP 
OF SBP(>20 mmHg) 
 
NO. OF PATIENTS 
 
PERCENTAGE 
Study ( Cirrhotics ) 6 12 
Control 0 0 
 
 12% of the Study Group show significant Postural Drop of SBP (>20 
mmHg) on standing which probably indicates sympathetic nervous system 
dysfunction. 
 
COMPARISON OF QTc PROLONGATION IN PATIENTS & 
CONTROLS 
 
GROUPS 
QTc 
PROLONGATION 
 
PERCENTAGE 
Study ( Cirrhotics ) 10 20 
Control 2 4 
 
 This study shows that QTc prolongation is common (20%) in patients 
when compared to Control Group (4%). 
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CHILD – PUGH GRADING & QTc PROLONGATION  
 
Child Grading 
 
No of Patients 
 
QTc Prolongation 
 
% 
A 4 0 0 
B 42 8 19 
C 4 2 50 
Total 50 10 20 
 
 There is a positive correlation between QTc Prolongation and increasing 
severity of Cirrhosis. 
CHILD – PUGH GRADING & CARDIAC DYSAUTONOMIA 
 
CHILD 
GRADING 
 
NO OF 
PATIENTS 
 
E: I RATIO <1.1 
 
PERCENTAGE 
A 4 0 0 
B 42 19 45 
C 4 4 100 
Total 50 23 46 
 
 There is a positive correlation between Disease Severity and 
Parasympathetic Dysfunction. 
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CORRELATION BETWEEN DISEASE SEVERITY & POSTURAL 
DROP OF SBP >20MMHG 
 
 
CHILD 
GRADING 
 
NO OF 
PATIENTS 
 
POSTURAL DROP 
OF SBP >20MMHG 
 
PERCENTAGE 
A 4 0 0 
B 42 4 9.5 
C 4 2 50 
Total 50 6 12 
 
 There is a positive correlation between Disease Severity and 
Sympathetic Dysfunction. 
  
This Study shows that all the patients with Sympathetic Dysfunction had 
Parasympathetic Dysfunction as well. 
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CORRELATION BETWEEN ALCOHOLISM & QTc PROLONGATION 
 
GROUPS 
 
NO. OF 
PATIENTS 
 
MEAN QTc INTERVAL 
Alcoholics 23 426.30 ± 37.11 
Non-Alcoholics 27 433.40 ± 45.22 
 
*t = 0.6 p = 0.55  *Unpaired‘t’ test  
 Both the Groups show that there is no statistically significant difference 
in QTc Interval.  
CORRELATION BETWEEN GI BLEED  & QTc INTERVAL 
GROUPS 
NO OF 
PATIENTS 
MEAN QTC INTERVAL 
Bleeders 34 428.176 ± 41.82 
Non-Bleeders 16 434.31 ± 41.62 
 
*t = 0.48  p = 0.63     *Unpaired‘t’ test  
 There is no statistically significant difference in QTc Interval between 
Bleeders & Non-Bleeders. 
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CORRELATION BETWEEN SEX OF THE PATIENT & QTc 
INTERVAL 
 
GROUPS 
 
NO OF 
PATIENTS 
 
MEAN QTc INTERVAL 
Male 39 435.61 ± 39.026 
Female 
 
11 410.72 ± 45.734 
*t = 1.8  p = 0.08 *Unpaired‘t’ test  
 There is no statistically significant difference in QTc Interval between 
Male and Female Patients. 
CORRELATION OF CARDIAC DYSAUTONOMIA BETWEEN 
BLEEDERS & NON-BLEEDERS 
PARASYMPATHETIC 
DYSFUNCTION 
BOTH(PARASYM 
& SYMP DYSFN) 
 
GROUP 
NO OF 
PATIENTS 
No of Pts % No of Pts % 
Bleeders 34 21 61.7 5 14.7 
Non-
bleeders 
16 2 12.5 1 6.2 
 
 This study shows Cardiac dysautonomia is commoner in Bleeders when 
compared to Non-Bleeders.  
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RESULTS 
 
1) The Resting Heart rate in Cirrhotics (90 ± 16.98 bpm) was significantly 
(p<0.05) higher than that of Controls (76.78 ± 11.23 bpm). 
 
2)The R-R Interval of Study group (690.54 ± 133.38 msec) is significantly 
lower than Control group (797.98 ± 119.17 msec) (p<0.005) correlating with 
increased resting heart rate signifying parasympathetic damage. 
 
3) Both Study (139.36 ± 19.09 msec) and Control Group (143.76 ± 18.62 msec) 
show no statistically significant difference in P-R Interval (p>0.05). 
 
4) The QRS Duration in Study Group( 77.68 ± 10.87 msec) and Control 
Group( 65.28 ± 12.77 msec) showed no statistically significant difference 
(p>0.05). 
 
5) The QRS Axis in Study Group (42.12 ± 31.64 degrees) and Control Group 
(48.92 ± 23.38 degrees) show no statistically significant difference  (p>0.05). 
 
6) The QTC Interval of Study group (430.14 +/- 41.43 msec) is significantly 
prolonged than Control group (376.36 +/- 36.54 msec) (p<0.005). 
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7) 46% of Study Group have abnormal E:I ratio which is suggestive of an early 
parasympathetic dysfunction. 
 
8) 12% of the Study Group show significant Postural Drop of SBP (>20 
mmHg) on standing which probably indicates sympathetic nervous system 
dysfunction. 
 
9) This study shows that QTc prolongation is common (20% ) in patients when 
compared to Control Group (4%). 
 
10) QTc prolongation was seen in none of the patients in Child ‘A’ , 19% in 
Child ‘B’ and 50% in Child ‘C’. So there is a positive correlation between QTc 
Prolongation and increasing severity of Cirrhosis. 
 
11) Parasympathetic Dysfunction (E: I Ratio <1.1) was seen in none of the 
patients in Child ‘A’ , 45% in Child ‘B’ and 100% in Child ‘C’. So there is a 
positive correlation between Disease Severity  & Parasympathetic Dysfunction. 
 
12) Sympathetic Dysfunction (Postural Drop of SBP >20mmHg) was seen in 
none of the patients in Child ‘A’ , 9.5% in Child ‘B’ & 50% in Child ‘C’. There 
is a positive correlation between Disease Severity & Sympathetic Dysfunction.  
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13) None of the patients had Sympathetic Dysfunction alone. All the patients 
with Sympathetic Dysfunction had Parasympathetic Dysfunction as well. 
 
14) There is no statistically significant difference in QTc Interval (p>0.05) 
between Alcoholics (426.30 ±37.11 msec) & Non-Alcoholics (433.4 ±45.22 
msec). 
 
15) There is no statistically significant difference in QTc Interval (p>0.05) 
between Bleeders (428.176 ± 41.82 msec) & Non-Bleeders (434.31 ± 41.62 
msec). 
 
16) There is no statistically significant difference in QTc Interval (p>0.05) 
between male (435.61 ± 39.026 msec) and female patients (416.72 ± 
45.734msec). 
 
17) Parasympathetic Dysfunction is seen in 61.7% of Bleeders & 12.5% of 
Non-Bleeders while both Parasympathetic & Sympathetic Dysfunction is seen 
in 14.7% of Bleeders & 6.2% of Non-Bleeders. So this study shows that 
Cardiac dysautonomia is commoner in Bleeders when compared to Non-
Bleeders.  
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DISCUSSION 
  
This study compares the ECG Changes of 50 Cirrhotic Patients with 
equal numbers of Age & Sex matched Control populations. By using various 
ECG Parameters, this study also delineates the prevalence of Autonomic 
Dysfunction in Cirrhosis with Portal Hypertension Patients. 
 
 The Mean Resting Heart Rate is found to be 90 bpm in the Study Group 
as compared to 76.78 bpm in the Control Group. Thus the Resting Heart Rate is 
nearly 12 bpm more in the Study Group than that of Control Group. 
 
 This is probably due to Cardiac Autonomic Dysfunction, more 
specifically parasympathetic damage. Ewing et al44have found that the 
parasympathetic nerves are the earliest to be involved followed by sympathetic 
nerves in autonomic neuropathy.  
 
 The Study (139.36 ± 19.09 msec) and Control Group (143.76 ± 18.62 
msec) showed no statistically significant difference in P-R Interval and QRS 
duration in the study. 
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The QRS Axis in Study Group (42.12 ± 31.64 degrees) and Control 
Group (48.92 ± 23.38 degrees) showed  no statistically significant difference  
(p>0.05). 
 
The QTC Interval of Study group (430.14 +/- 41.43 msec) is 
significantly prolonged than that of Control group (376.36 +/- 36.54 msec) 
(p<0.005). 
 
This study showed that QTc prolongation (20% of patients) is a frequent 
finding in patients with liver disease. The prolongation of QTc interval 
correlated with the severity of liver damage and occurred independent of 
etiology. This data also confirm previous observations that autonomic 
dysfunction is common in patients with chronic liver disease irrespective of 
etiology. 1, 45 
 
 Govin et al46  stated that QTc prolongation can be taken as a marker of 
autonomic neuropathy, especially cardiac sympathetic innervation damage. 
 
IMPLICATIONS OF PROLONGED QTc  INTERVAL 
1) For identifying patients who are prone to syncopal attack 
due to ventricular arrhythmia. 
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2) Among patients with previous MI a prolonged QTc interval 
doubles the risk of sudden death. 
3) QT prolongation is one of the primary electrical syndromes 
responsible for sudden cardiac death, so measurement of the 
same in the ECG of Cirrhotics is of paramount importance 
of assessing the risk of sudden cardiac death. 
 
In my Study, Parasympathetic Dysfunction is seen in 46% of patients 
whereas Sympathetic Dysfunction is seen in 12% of patients. All patients with 
Sympathetic Dysfunction also showed evidence of Parasympathetic 
Dysfunction. 
 
In a study done by Bajaj et al, 16 of the 20 cirrhotics (80%) were found 
to have an abnormal result in one or more autonomic function tests47. However, 
Barter and Tanner in their study of 30 subjects reported evidence of 
parasympathetic damage in 16% and of combined parasympathetic and 
sympathetic neuropathy in an additional 20%48. The lower frequency of 
autonomic dysfunction in their study could be due to the fact that they included 
only 14 subjects with alcoholic liver disease while the rest had an alcohol 
dependence problem only. Szalay et al in their evaluation of 121 patients with 
chronic alcoholism—33 without liver disease, 33 with fatty liver, 33 with 
cirrhosis, 10 with biliary cirrhosis, and 12 with cirrhosis of another origin— 
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found autonomic reflex damage in all.49 They observed significantly more 
damage in those with liver disease.  
 
Hendrickse and Triger reported cardiovascular autonomic dysfunction 
with predominantly parasympathetic abnormality in 35% of the patients with 
chronic liver disease.50Hendrickse et al in another study reported vagal 
neuropathy in 45% of the 60 patients of chronic liver disease studied.43 The 
vagal function was more commonly affected than the sympathetic function.  
 
Although this disparity may reflect an earlier impairment of the vagal 
branch owing to possibly greater vulnerability of parasympathetic fibers,51 the 
fact that tests based on heart rate changes are much more sensitive than those 
based on blood pressure variations in revealing subtle autonomic defects cannot 
be overlooked.52 In fact, when the sympathetic pathway was evaluated with the 
sweat test, which has a higher sensitivity, the prevalence of its alteration 
approached that of vagal dysfunction.53 Similar findings were also observed by 
evaluating beat-to-beat fluctuation in heart rate by power spectral analysis.54 
Gentile et al found autonomic neuropathy in 60% (71% in the alcoholic group 
and 57% in the non-alcoholic group) of the 113 cirrhotics studied.55 Like in the 
present study, alteration of parasympathetic function was significantly more 
frequent than that of sympathetic function. Dillon et al also detected abnormal 
cardiovascular reflexes in 60% of 70 cirrhotics56. 
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In the present study, 19 (45%) out of 42 patients belonging to Child 
class B had autonomic dysfunction while all the four (100%) patients in class C 
had impaired autonomic function. These findings are similar to the 
observations of most other studies, which reported increasing frequency of 
autonomic dysfunction with increasing severity of liver damage. Hendrickse 
and Triger reported a strong correlation between the abnormal tests and Child-
Pugh score (p<0.0001).43 In their study, they found autonomic dysfunction in 
69% of Child class B and C patients and 23% in class A patients (p<0.0001) 
.  
This study also shows that bleeders have more incidence of autonomic 
dysfunction(61.7% parasympathetic & 14.7% sympathetic dysfunction) when 
compared to non bleeders (12.5 % parasympathetic & 6.2% sympathetic 
dysfunction). This has to be confirmed by further studies. Finally, considering 
the adverse prognostic implications of autonomic neuropathy reported in 
cirrhotics, further prospective studies involving a larger number of patients are 
warranted to delineate the factors responsible for the derangement and find 
remedial measures if possible. 
 
 
 
 
  53 
 
 
 
CONCLUSION 
 
This study has shown that autonomic dysfunction is very common in 
cirrhotic patients. The incidence of autonomic dysfunction also increases with 
increasing severity of liver disease. This study also highlights the importance of 
simple bedside investigations like ECG and clinical evaluation in early 
diagnosis of autonomic dysfunction. 
 
The mortality of cirrhosis patients is partly related to poor autonomic 
responses to stressful events like sepsis or bleeding. On the basis of this 
evidence, it is suggested that consideration should be given for early liver 
transplantation in patients with autonomic neuropathy. These patients should 
also be given intensive care in the per-operative and post-operative period to 
decrease the mortality rate. 
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PROFORMA 
1. Name: 
2. OP/IP Number: 
3. Age: 
4. Sex: 
5. Diagnosis: 
6. Etiology: 
7. Duration: 
8. Child’s grade: 
9.  H/O Postural giddiness: 
10.H/O Smoking: 
11.H/O Alcoholism: 
12.H/O Bleed: 
13.LFT: 
14.Ascites: 
15.Splenomegaly: 
16.Pulse: 
17.Blood pressure: 
                1.supine: 
                2.standing:   
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CARDIOVASCULAR SYSTEM 
 
ELECTROCARDIOGRAM 
 
1.Rate 
2.R-R interval 
3.P-R interval 
4.QRS Duration 
5.QRS Axis 
6.QTc interval 
7.E:I Ratio 
8.Maximum- minimum heart rate 
9.ST-T changes 
 
ECHOCARDIOGRAPHY 
MASTER CHART- STUDY GROUP 
 
Sl.no MGE.NO Name age sex h/o pos. giddiness Etiology 
Duration 
(years) Child's 
Rate 
bpm 
 
RR 
 
PR QRS axis QTc ST-T E:I 
ratio Pos.Hyp bleed 
1 1076/06 Arumugam 46 M + 1 1 B 71 845 170 40 41 420 - 1.1 - + 
2 4001/05 Gomathy 35 F + 4 1 B 94 638 100 60 90 400 - 1.06 - + 
3 994/06 Kavitha 28 F - 4 1 B 94 638 160 60 25 455 - 1.09 - + 
4 894/06 Thaimani 55 F - 2 1 B 101 594 132 80 32 456 - 1.11 - - 
5 5456/05 Elavarasi 16 F - 2 1 B 103 582 140 60 45 408 + 1.13 - + 
6 5682/05 Rohini 13 F - 4 2 A 97 619 135 100 18 457 + 1.12 - + 
7 61/06 Krisnan 16 M - 3 1 B 119 504 108 40 23 501 - 1.07 - + 
8 6538/04 Panch 41 M + 1 2 B 64 938 144 40 39 458 - 1.13 - + 
9 4538/05 Balakrisnan 57 M - 4 3 B 66 909 120 60 -30 480 - 1.08 + + 
10 652/00 Velusamy 47 M - 1 6 B 68 882 160 60 60 392 - 1.11 - + 
11 438/04 Natarajan 48 M - 2 1 B 79 760 160 60 30 459 - 1.1 - - 
12 216/06 Munir 38 M + 1 1 B 113 520 148 80 81 466 + 1.1 - - 
13 4136/05 Pitchai 36 M - 1 2 B 82 732 144 40 65 434 - 1.09 - + 
14 406/06 Ravi 41 M - 1 1 C 133 451 144 40 39 357 - 1.09 + + 
15 547/05 Sundaram 48 M - 4 1 B 88 682 160 80 120 376 - 1.04 - + 
16 2349/04 Asokan 37 M - 2 14 B 100 600 144 40 13 480 - 1.09 + + 
17 5799/03 Chandran 42 M + 4 4 B 72 833 168 60 85 420 - 1.1 - + 
18 6329/05 Ramesh 45 M - 1 2 B 63 952 132 40 76 432 - 1.1 - - 
19 106/06 Ravindran 29 M - 1 4 B 67 896 136 40 5 448 - 1.11 - + 
20 286/06 Varadarajan 51 M - 1 4 B 107 562 100 60 70 373 - 1.06 - + 
21 1168/05 Govindan 50 M - 2 1 B 83 723 176 60 40 489 - 1.07 - + 
22 1034/05 Sures babu 32 M - 1 1 C 110 545 140 40 20 476 - 1.07 - + 
23 1214/06 Kumar 40 M - 1 1 A 88 682 140 60 30 439 - 1.14 - + 
24 2429/03 Mariammal 55 F - 4 3 B 88 682 130 40 15 376 - 1.15 - - 
25 1082/06 Kasthuri 41 F - 4 1 B 100 600 120 100 10 350 - 1.11 - - 
 
Sl.no MGE.NO Name age sex h/o pos. giddiness Etiology 
Duration 
years Child's rate RR PR QRS axis QTC ST-T E:I ratio Pos.Hyp bleed 
26 3233/05 Naraiah 45 M + 2 1 B 83 723 164 40 36 432 - 1.1 - + 
27 4568/04 Rajeswari 58 F - 2 1 B 94 638 144 40 30 480 - 1.12 - - 
28 267/03 Parvathi 38 F + 4 1 B 88 682 110 60 84 412 - 1.04 - + 
29 6284/05 Perumal 31 M - 4 1 B 97 618 132 60 39 456 - 1.08 - + 
30 0009/04 Nazeer 14 M - 3 1 B 115 521 110 60 30 480 - 1.08 - - 
31 4008/05 Palani 55 M - 4 3 B 75 800 120 60 -36 438 - 1.09 + - 
32 3367/05 Abu becr 40 M + 1 1 B 107 562 148 60 76 460 + 1.1 - - 
33 4847/05 Satish 14 M - 2 1 B 100 600 144 45 40 410 + 1.14 - - 
34 4441/04 Balaji 13 M - 4 2 A 94 638 135 60 20 450 + 1.13 - - 
35 3853/03 Gunalan 37 M - 1 4 B 68 882 136 60 8 450 - 1.12 - - 
36 5252/05 Guru nadan 42 M + 1 2 B 66 909 144 60 40 460 - 1.12 - - 
37 2832/04 Hari babu 35 M - 1 2 B 80 750 144 40 66 436 - 1.09 - + 
38 45598 Jayadev 40 M - 1 2 B 84 714 140 60 60 430 - 1.08 - + 
39 1034/02 Jayalaxmi 40 F - 4 1 B 102 588 124 60 12 352 - 1.11 - - 
40 3980/05 Kalifath 33 M - 1 1 C 108 555 144 40 18 474 - 1.06 - + 
41 2404/01 Katija 56 F - 4 3 B 90 667 128 60 18 372 - 1.13 - + 
42 2759/05 Balamurugan 41 M - 1 1 A 86 698 136 40 32 442 - 1.12 - + 
43 5394/03 Durairaj 49 M - 4 1 B 91 659 154 60 116 372 - 1.06 - + 
44 64703 Doss 42 M - 1 1 C 120 500 136 80 42 350 - 1.08 + + 
45 650/06 Ellappan 49 M - 1 4 B 110 545 96 60 66 372 - 1.07 - + 
46 61472 Jayavel 38 M - 2 9 B 98 612 140 40 17 456 - 1.07 + + 
47 4851/04 Sampath 45 M - 1 4 B 70 857 156 60 56 390 - 1.12 - + 
48 3115/05 Anthoni 45 M + 1 1 B 74 811 168 40 72 416 - 1.12 - + 
49 4439/05 Babu 50 M - 2 1 B 85 706 174 40 42 485 - 1.09 - + 
50 3125/03 Balaji 1 44 M - 1 2 B 65 923 130 80 80 430 - 1.12 - - 
Etiology:1- alcoholism, 2- viral, 3- metabolic, 4- others 
 
 
 MASTER CHART- CONTROL GROUP 
 
Sl.no Name IP no Age Sex H/o post. giddiness Pulse Post hypo Rate RR PR QRS QRS axis QTc ST-T 
1 Manalan 245364 47 M - 76 - 76 790 124 60 88 352 + 
2 Jaya 256021 37 F - 66 - 66 914 164 60 72 370 - 
3 Ravi 100236 46 M - 76 - 76 790 184 60 64 312 - 
4 Palani 105638 45 M - 83 - 83 723 160 60 46 330 - 
5 Ram kumar 100114 37 M - 58 - 58 1035 138 80 60 396 - 
6 Santhanam 225472 36 M - 78 - 78 769 140 60 64 364 - 
7 Muthiah 105488 41 M - 100 - 100 600 120 70 90 372 - 
8 Udayan 16734 48 M - 92 - 92 652 118 40 72 363 + 
9 Mary 201965 53 F - 62 -  62 968 146 60 43 405 + 
10 Balakumar 10087 42 M - 71 -  71 845 142 60 47 409 - 
11 Banumathi 29475 38 F - 68 -  68 882 120 60 61 371 - 
12 Ilavarasu 25678 48 M - 66 - 66 909 158 40 53 375 - 
13 Barathi 217131 45 M - 72 - 72 833 140 60 28 374 - 
14 Sathya 29587 28 F - 80 -  80 750 142 40 3 364 - 
15 Sivagami 29544 57 F - 86 - 86 698 124 40 28 330 - 
16 Selvam 27563 44 M - 68 - 68 882 156 60 52 388 - 
17 Sivaraj 16574 43 M - 78 - 78 769 120 60 24 360 - 
18 Appusamy 28536 48 M - 70 -  70 857 130 40 0 398 - 
19 Madavan 25567 40 M - 76 - 76 790 148 60 30 345 - 
20 Balan 25638 46 M - 80 - 80 750 123 60 44 331 - 
21 Santhy 182309 42 F - 90 - 90 667 120 60 26 372 - 
22 Kamal 19986 44 M - 60 - 60 1000 124 60 36 336 + 
23 Muniammal 24378 58 F + 82 - 82 732 124 60 12 453 - 
24 Nagaraj 34562 52 M - 72 - 72 833 140 60 70 366 + 
25 Palraj 102456 38 M - 72 - 72 833 128 80 62 346 - 
 Sl.no Name IP no Age Sex H/o post. giddiness Pulse Post hypo Rate RR PR QRS QRS axis QTc ST-T 
26 Begam 28891 56 F + 80 - 80 750 128 70 24 336 - 
27 Sanmugam 199827 35 M - 72 - 72 833 124 84 40 384 - 
28 Eswar 42336 42 M - 68 - 68 882 142 46 54 380 - 
29 Muthammal 102455 41 F - 82 - 82 732 164 60 32 360 - 
30 Gandhi 178203 43 M - 92 - 92 652 160 70 64 372 - 
31 Pandi 132456 40 M - 80 - 80 750 134 64 2 378 - 
32 Anthoni 27420 48 M - 90 - 90 667 144 72 60 406 + 
33 Janakiraman 133245 46 M - 56 - 56 1071 164 46 90 416 - 
34 Ramesh 132457 29 M - 58 - 58 1034 154 60 76 320 - 
35 Riwan 35679 49 M - 86 - 86 698 148 80 100 396 - 
36 Periyasamy 23158 36 M - 72 - 72 833 146 48 43 352 - 
37 Kuppan 67890 48 M - 87 - 87 670 148 54 28 372 - 
38 Munusamy 56429 41 M - 89 - 89 674 129 64 47 346 - 
39 Baskar 83256 36 M - 76 - 76 790 164 70 30 360 + 
40 Vedachalam 72891 55 M - 70 - 70 857 140 64 45 385 - 
41 Murali  15347 40 M - 86 - 86 698 126 42 50 405 - 
42 Gangadar 23145 32 M - 62 - 62 968 184 72 70 372 - 
43 Farida 12684 17 F - 108 - 108 560 200 78 60 474 - 
44 Rahman 35242 29 M - 58 - 58 1034 136 88 46 391 - 
45 Priya 24567 18 F - 77 - 77 779 148 70 70 498 - 
46 Kannan 14425 55 M - 72 - 72 833 140 64 39 382 - 
47 Sekar 12987 14 M - 88 - 88 682 153 74 24 348 - 
48 Devaraj 53426 16 M - 78 - 78 769 168 104 74 443 - 
49 Arun 23145 15 M - 86 - 86 698 147 82 72 396 - 
50 Krishnan 9437 15 M - 84 - 84 714 164 60 31 364 - 
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